PAS
FLNA

Point72 Asia (Singapore)’s Filana Therapeutics FLNA Stock Holding History

Point72 Asia (Singapore)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$50.6K Sell
17,372
-17,370
-50% -$39.9K 0.01% 562
2025
Q2 		$62.9K Buy
+34,742
New +$61.8K 0.01% 549

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asia (Singapore)'s FLNA Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Filana Therapeutics (FLNA) stake by 50% in Q3 2025, selling an estimated $39.9K and leaving 17,372 shares worth $50.6K. The position accounts for 0.01% of the portfolio, ranked #562.

Point72 Asia (Singapore) first reported a position in FLNA in Q2 2025 and has held it in 2 quarters since. The position peaked at $62.9K in Q2 2025. 103 funds tracked by Wall St. Rank hold FLNA as of Q3 2025.

  • Point72 Asia (Singapore) held 17,372 shares of Filana Therapeutics worth $50.6K as of Q3 2025.
  • Point72 Asia (Singapore) sold 17,370 Filana Therapeutics shares in Q3 2025, an estimated $39.9K.
  • Filana Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #562 holding.
  • Point72 Asia (Singapore) first reported a position in Filana Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Filana Therapeutics position peaked at $62.9K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.